Factors Associated with PCV13 Vaccine Hesitancy in Parents under an Innovative Immunization Strategy: a Cross-Sectional Study — Weifang City, Shandong Province, China, 2021

WHAT IS ALREADY KNOWN ON THIS TOPIC? Pneumococcal diseases (PDs) are serious threats to child health. Although vaccination is one of the most effective ways to prevent these diseases, the pneumococcal vaccination coverage rate is still relatively low in China. WHAT IS ADDED BY THIS REPORT? This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yuanze, Wang, Yan, Zhang, Ting, Ma, Libing, Xie, Shuyun, Wang, Yi, Yang, Yuan, Li, Juanjuan, Feng, Yushu, Wang, Yujue, Qi, Weiran, Yang, Weizhong, Zhou, Jian, Wang, Chunping, Feng, Luzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150748/
https://www.ncbi.nlm.nih.gov/pubmed/37138893
http://dx.doi.org/10.46234/ccdcw2023.049
Descripción
Sumario:WHAT IS ALREADY KNOWN ON THIS TOPIC? Pneumococcal diseases (PDs) are serious threats to child health. Although vaccination is one of the most effective ways to prevent these diseases, the pneumococcal vaccination coverage rate is still relatively low in China. WHAT IS ADDED BY THIS REPORT? This study investigated the factors associated with 13-valent pneumococcal conjugate vaccine (PCV13) vaccine hesitancy in parents under an innovative immunization strategy. This study found that 29.7% of the participants hesitated to vaccinate their children against PCV13 and the main reasons for vaccine hesitancy were individual and group influences. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? This study can provide scientific evidence for further improving children’s PCV13 vaccination rate and improving the prevention and control strategy for PDs.

Ejemplares similares